ReviewBritish journal of clinical pharmacology2013

The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.

Ruth Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.